Expression of PD1 and PDL1 as immune-checkpoint inhibitors in mantle cell lymphoma

BACKGROUND: Mantle cell lymphoma (MCL) has remained incurable in most patients. The expression of PD-L1 as a prognostic and predictive marker has not been fully evaluated in MCL. The current study aimed to determine PD-1/PD-L1 expression in MCL specimens and its significance as an immune check point...

Descripción completa

Detalles Bibliográficos
Autores principales: Ameli, Fereshteh, Shajareh, Elham, Mokhtari, Maral, Kosari, Farid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351258/
https://www.ncbi.nlm.nih.gov/pubmed/35922773
http://dx.doi.org/10.1186/s12885-022-09803-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351258/
https://www.ncbi.nlm.nih.gov/pubmed/35922773
http://dx.doi.org/10.1186/s12885-022-09803-x

Ejemplares similares